Historical record - last NADAC publication: 11/12/2014
Product Information
TIAZAC ER 360 MG CAPSULE is a brand product labeled by Bausch Health US LLC, priced at $2.7628 per EA under NDC 00187261630. Its NADAC has been published 45 times since Nov 12, 2014.
The High Outlier badge above means this manufacturer's average price in the diltiazem hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
360 mg/1
Manufacturer
Bausch Health US LLCNDC
00187261630
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
11/12/2014
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020401On Market Since
8/20/2014
Pharmacological Classes
Price Statistics
The NADAC for TIAZAC ER 360 MG CAPSULE has been published 45 times since Nov 12, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7628 per EA |
|---|---|
| All-time high | $2.7628 (Sep 16, 2015) |
| All-time low | $2.7628 (Nov 12, 2014) |
| Median price | $2.7628 |
| Average price | $2.7628 |
| Largest weekly change | 0.0% (Nov 19, 2014) |
| Weeks tracked | 45 |
| Tracking since | Nov 12, 2014 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TIAZAC ER 360 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIAZAC ER 360 MG CAPSULE, manufactured by Bausch Health US LLC, is $2.7628 per EA (NDC 00187261630), effective Sep 16, 2015.
How has the price of TIAZAC ER 360 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIAZAC ER 360 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 45 weekly CMS publications since Nov 12, 2014.
What are the highest and lowest recorded NADAC prices for TIAZAC ER 360 MG CAPSULE?
Since Nov 12, 2014, the NADAC for TIAZAC ER 360 MG CAPSULE has ranged from a low of $2.7628 (Nov 12, 2014) to a high of $2.7628 (Sep 16, 2015), with a median of $2.7628 per EA.
Are there cheaper alternatives to TIAZAC ER 360 MG CAPSULE?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TIADYLT ER 360 MG CAPSULE, is $0.3165 per EA — about 89% below TIAZAC ER 360 MG CAPSULE.
Who manufactures TIAZAC ER 360 MG CAPSULE?
TIAZAC ER 360 MG CAPSULE (NDC 00187261630) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification